Crossmark Global Holdings Inc. has initiated a new position in NXP Semiconductors N.V. by purchasing 50,071 shares valued at approximately $11.9 million during the third quarter. Institutional investors now collectively own 90.54% of NXPI's outstanding stock. Despite recent price target reductions by some analysts, the company's Q3 earnings beat estimates, and the stock maintains a "Moderate Buy" consensus rating with an average target price of $302.30.

Western Digital reported a significant increase in fiscal first-quarter profit and revenue, driven by strong demand for data storage, particularly from the build-out of artificial intelligence infrastructure. The company's CEO noted sustained demand for hard disk drives from both core and new customers, including neoclouds and AI frontier labs. The company also announced a lifted dividend.

Verizon Communications Inc. shares, along with AT&T and T-Mobile, declined in after-hours trading following a Bloomberg report that SpaceX is negotiating access to 80,000 U.S. cell sites. This move could enable Starlink to build its own wireless network, posing a potential threat to existing carriers. The stock movement also precedes Verizon's third-quarter earnings report.

Upland Software, Inc. announced it will host a conference call on Thursday, November 5, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2026. The company's financial results will be released via press release after market closes on Wednesday, November 4, 2026. Interested parties can access the call via webcast or by dialing specified toll-free or international numbers.

Argus has raised its target price for Paycom Software, Inc. (PAYC) to $289.00, up from its previous target. The report, published on October 21, 2026, highlights Paycom's role as a human capital management software-as-a-service provider offering solutions for payroll, talent acquisition, HR management, and time and labor. The current stock price for PAYC is $272.61.

Marilyn Matz, a Director at Teradyne Inc. (TER), filed a Form 4 report detailing transactions for October 21st. The article from Investing.com focuses on this insider trading activity, which is a routine disclosure required by the SEC for company insiders. Teradyne's stock price experienced a decline of 10.63% in connection with this news.

T-Mobile US (TMUS) stock may be undervalued despite a recent analyst upgrade, trading around US$158.79. The company has seen a 43.9% return over the past five years, and its current P/E ratio of 16.1x is slightly above the industry average but significantly lower than some peers, suggesting potential undervaluation based on its fundamentals and growth profile. Analysts project continued strong earnings, further supporting the view that the stock's current price does not fully reflect its future potential.

Assenagon Asset Management S.A. significantly reduced its stake in DoubleVerify Holdings, Inc. ($DV) by selling over 1.3 million shares, retaining a smaller position valued at approximately $845,000. Despite this, institutional investors collectively own a substantial 97.29% of the company's shares, with some, like State Street and Manufacturers Life, increasing their holdings. Analysts generally rate DoubleVerify as a "Hold" with an average price target of $13.52, following a recent quarter where the company surpassed EPS estimates but fell short on revenue forecasts.

Apple's new foldable iPhone Duo launched with high demand but limited supply, leading to long lines at stores globally. Despite its premium price of up to $3,199, consumer interest is strong, reminiscent of early iPhone launches where demand far outstripped availability. The device, a significant design change for Apple, faces production challenges due to its advanced hinge and display technology, causing delivery delays until January for new orders.

Argus has raised its target price for CorVel Corp. (CRVL) to $89.00, citing the company's application of advanced technologies like AI, machine learning, and natural language processing to manage healthcare costs. The current price of CRVL is $83.88.